Natural products andpharmacological medications targeting IL-10 (57), MDM2 (9), BCL11A (58), and HO-1 (59) have been shown to be effective in clinical and pre-clinical studiesinvolving other diseases and may also be effective in treating patients with VFL andpreventing the onset of cancer. The gene discussed is BCL11A; the disease is cancer.